文献速递产科母胎医学

产后静脉血栓与家族史:瑞典全国性家庭研究

Postpartum Venous Thrombosis in Sweden: A Nationwide Family Study.
PubMed 文献 · Am J Obstet Gynecol · 2026-10-07

该研究基于瑞典856,380名无VTE史的初产妇,随访产后90天内VTE事件。家族史中 grandparents、父母、全同胞及半同胞的VTE均与产后VTE风险升高相关,遗传评分呈剂量反应模式。结论:VTE家族史是产后VTE的剂量分级风险因素。

要点

  • VTE家族史(父母、同胞)与产后VTE风险升高相关,且随受累亲属数量和遗传相关程度呈剂量分级。
  • 遗传评分最高类别(≥1.75分)者产后VTE风险为无家族史者的3.66倍(95%CI 2.06-6.51)。
  • 肥胖、癌症、SLE、静脉曲张、妊娠高血压、子痫前期/子痫、胎盘早剥、子宫内膜炎/产褥热、剖宫产及产后出血输血状态亦为独立预测因素。

核心结论

  • VTE家族史是产后VTE的剂量分级风险因素,风险随受累亲属数量和遗传相关程度增加而升高。

研究设计与样本

  • 全国性 population-based 队列研究,纳入1992-2018年瑞典856,380名无VTE史的初产妇,随访产后90天内VTE事件。
  • 通过瑞典多代登记识别亲属,暴露为祖父母、父母、全同胞、半同胞、堂表亲及配偶的VTE家族史。
  • 构建遗传评分(祖父母0.5分、父母1分、全同胞1分、半同胞0.5分、堂表亲0.25分),分4类:0分、0.25-1分、1.25-1.5分、≥1.75分。
  • 采用Cox比例风险模型多变量调整,估计HR及95%CI。

主要发现

  • 共788名(0.09%)发生产后VTE。
  • 祖父母VTE家族史HR=1.41(95%CI 1.21-1.64);父母HR=2.03(95%CI 1.60-2.56);全同胞HR=2.55(95%CI 1.53-4.26);半同胞HR=2.28(95%CI 1.08-4.80)。
  • 遗传评分类别1的完全调整HR=1.50(95%CI 1.29-1.74);类别2 HR=2.89(95%CI 2.01-4.16);类别3 HR=3.66(95%CI 2.06-6.51),呈剂量反应模式。
  • 完全调整模型中其他独立预测因素包括肥胖、癌症、系统性红斑狼疮、静脉曲张、妊娠高血压、子痫前期或子痫、胎盘早剥、子宫内膜炎或产褥热、剖宫产及产后出血输血状态。

关键数值与推荐

  • 遗传评分类别1(0.25-1分)产后VTE风险HR=1.50(95%CI 1.29-1.74)。
  • 遗传评分类别2(1.25-1.5分)HR=2.89(95%CI 2.01-4.16)。
  • 遗传评分类别3(≥1.75分)HR=3.66(95%CI 2.06-6.51)。

临床怎么用

  • 对于无既往VTE史的初产妇,应详细采集VTE家族史(包括祖父母、父母、同胞、半同胞及堂表亲)。
  • 可根据受累亲属数量及遗传相关程度量化家族史风险,遗传评分较高者产后VTE风险显著增加。
  • 结合其他独立预测因素(如肥胖、子痫前期、剖宫产、产后出血输血等)综合评估产后VTE风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postpartum venous thromboembolism (VTE) is a serious complication. The importance of family history of VTE remains unclear in the postpartum period. OBJECTIVE: To assess the importance of family history of VTE for postpartum VTE among primiparous women without previous VTE. STUDY DESIGN: This nationwide population-based cohort study included 856,380 Swedish primiparous women between 1992-2018, without a history of VTE, followed for incident postpartum VTE within 90 days after delivery. Relatives were identified through the Swedish Multi-Generation Register. The exposure was family history of VTE in grandparents, parents, full siblings, half siblings, cousins, and spouses. A hereditary score consisting of four categories was constructed based on affected biological relatives and their degree of genetic relatedness. VTE in a grandparent contributed 0.5 points, VTE in a parent 1 point, VTE in a full sibling 1 point, VTE in a half sibling 0.5 points, and VTE in a cousin 0.25 points. Reference category 0=0 points, category 1=0.25-1 points, category 2=1.25-1.5, and category 3 ≥1.75 points. Cox proportional hazards models with multivariable adjustment were used to estimate hazard ratios (HRs) with 95% confidence intervals (CI). RESULTS: A total of 788 women (0.09%) developed postpartum VTE. Family history in grandparents (HR=1.41, 95% CI 1.21-1.64), parents (HR=2.03, 95% CI 1.60-2.56), full sibling (HR=2.55, 95% CI 1.53-4.26), and half siblings (HR=2.28, 95% CI 1.08-4.80) was associated with increased VTE risk. The hereditary score showed a clear dose-response pattern compared with those without family history: the fully adjusted HR was 1.50 (95% CI 1.29-1.74) for the hereditary score category 1, HR=2.89 (95% CI 2.01-4.16) for the score category 2, and HR=3.66 (95% CI 2.06-6.51) for the score category 3. Additional independent predictors for VTE in the fully adjusted model were obesity, cancer, systemic lupus erythematosus, varicose veins, gestational hypertension, preeclampsia or eclampsia, placental abruption, endometritis or puerperal fever, caesarean delivery, and postpartum hemorrhage-blood transfusion status. CONCLUSIONS: Family history of VTE is a dose-graded risk factor for postpartum VTE, with the risk increasing according to the number of affected relatives and degree of genetic relatedness.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Ben Saleh M, Pirouzifard M, Lindqvist PG, et al. Postpartum Venous Thrombosis in Sweden: A Nationwide Family Study. Am J Obstet Gynecol. 2026. PMID: 42843583. doi:10.1016/j.ajog.2026.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。